Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.
Reports book value and tangible book value per share of $28.66 and $24.51 at December 31, 2024, compared to $28.81 and $24.64 at September 30, ...
Alliance Resource Partners LP (NASDAQ:ARLP) reported its fourth-quarter 2024 earnings, missing analyst expectations with an earnings per share (EPS) of $0.12 against a forecast of $0.70. The company's ...
Google Search and YouTube revenues are projected to grow at 10% and 11%, respectively in Q4, showing slower growth compared ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Stock analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for ACADIA Pharmaceuticals in a research report ...
AppFolio's Q4 2024 earnings report highlights the company's robust revenue growth and strategic advancements, though the EPS ...
Nokia's earnings exceeded expectations despite a slight revenue miss.
AbbVie reported that GAAP Q4 EPS came to $(0.02), and full-year 2024 GAAP EPS came to $2.39 for the full year, with a $0.88 and $1.52 per share hit from Acquired IPR&D and Milestones Expense ...
Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...
Revenue only grew 2 percent year over year for Tesla in Q4 2024.
Swiss drug-major Novartis AG reported Friday weak net earnings in its fourth quarter on the absence of prior year's significant gain ...
Novartis reported strong Q4 earnings and sales growth, with CEO Narasimhan reportedly downplaying concerns over Entresto's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback